Study on a fermented whole wheat: Phenolic content, activity on PTP1B enzyme and in vitro prebiotic properties by Balli, D. et al.
molecules
Article
Study on a Fermented Whole Wheat: Phenolic
Content, Activity on PTP1B Enzyme and In Vitro
Prebiotic Properties
Diletta Balli 1, Maria Bellumori 1, Paolo Paoli 2 , Giuseppe Pieraccini 3, Monica Di Paola 4 ,
Carlotta De Filippo 5, Diana Di Gioia 6 , Nadia Mulinacci 1,* and Marzia Innocenti 1
1 Department of NEUROFARBA, and Multidisciplinary Centre of Research on Food Sciences
(M.C.R.F.S.- Ce.R.A.), University of Florence, Via Ugo Schiff 6, 50019 Sesto F.no Firenze, Italy;
diletta.balli@unifi.it (D.B.); maria.bellumori@unifi.it (M.B.); marzia.innocenti@unifi.it (M.I.)
2 Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence,
Viale G.B. Morgagni 50, 50139 Firenze, Italy; paolo.paoli@unifi.it
3 Mass Spectrometry Center (CISM), Department of Health Sciences, University of Florence,
Viale G. Pieraccini 6, 50139 Firenze, Italy; giuseppe.pieraccini@unifi.it
4 Department of Biology, University of Florence, Via Madonna del Piano, 6, Sesto Fiorentino,
50019 Firenze, Italy; monica.dipaola@unifi.it
5 Institute of Agricultural Biology and Biotechnology, National Research Council, Via G. Moruzzi 1,
56124 Pisa, Italy; carlotta.defilippo@ibba.cnr.it
6 Department of Agricultural and Food Sciences (DISTAL), University of Bologna, Viale Fanin 42,
40127 Bologna, Italy; diana.digioia@unibo.it
* Correspondence: nadia.mulinacci@unifi.it; Tel.: +39-055-4573773
Academic Editors: Mingfu Wang and Yueliang Zhao
Received: 22 February 2019; Accepted: 19 March 2019; Published: 21 March 2019


Abstract: Fermented cereals, staple foods in Asia and Africa, are recently receiving a growing interest
in Western countries. The object of this work is the characterization of a fermented wheat used as a
food ingredient and dietary supplement. To this aim, the phenolic composition, the activity on protein
tyrosine phosphatase 1B (PTP1B), an enzyme overexpressed in type-II diabetes, the in vitro prebiotic
properties on Lactobacillus reuteri and the microbial composition were investigated. Basic and acidic
hydrolysis were tested for an exhaustive recovery of bound phenols: the acidic hydrolysis gave best
yields. Methyl ferulate and neocarlinoside were identified for the first time in wheat. The inhibitory
power of the extracts of several batches were investigated on PTP1B enzyme. The product was
not able to inhibit the enzyme, otherwise, for the first time, a complete inhibition was observed
for schaftoside, a major C-flavonoid of wheat. The microbial composition was assessed identifying
Lactobacillus, Enterococcus, and Pediococcus as the main bacterial species. The fermented wheat was
a suitable substrate for the grown of L. reuteri, recognized for its health properties in the human
gut. The proposed method for phenols is easier compared to those based on strong basic hydrolysis;
our results assessed the bound phenols as the major fraction, differently from that suggested by the
literature for fermented cereals.
Keywords: cereal; schaftoside; methyl ferulate; Lactobacillus reuteri
1. Introduction
Cereal fermentation is an ancient technique applied to improve food texture, shelf-life, digestibility,
and food preservation, as well as able to remove anti-nutritional factors and toxins. It is a widely
applied practice in Asian and African cultures where cereals, as staple crops, are processed before
consumption. In recent years, there has been renewed interest in fermented foods in Europe, especially
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for the supposed health benefits linked to these foods [1]. The fermentation of cereal is reported as
useful for the release as well the production of a greater amount of free phenolic compounds with
respect to the unfermented substrate. This may be due to breakage of the link between bound phenols
and the cell wall, but also to the induced synthesis of bioactive compounds determined by microbial
communities during the fermentation process [2,3]. The main classes of phenolic compounds in
cereals are benzoic derivatives, cinnamic acids, and flavonoids; they can be present in free or bound
forms (esterified or etherified), linked to polysaccharides, proteins, lignin and cutin, or other cell wall
constituents [4]. The literature points out that bound phenols are the main compounds responsible for
the antioxidant capacity of cereals. The fermentation process, in vivo modifying the structure of the
fibre constituents, leads to the formation of substrates transformed by colonic bacteria with beneficial
effects on gut bacterial composition, and protective activity against several diseases and stresses [5].
A fermented product from wheat (Triticum aestivum), used as food ingredient and food
supplement, is Lisosan® G. The production is from the wholegrain, grounded, added with water and
a sourdough starter, than mixed to initiate the fermentation process, the whole product is recovered
after three days, and dried. Recently, Lisosan® G has been object of in vivo and ex vivo studies, but
few data are available on its composition. A protective activity was observed on Wistar rats fed with
different dosages of Lisosan® G before the use of cisplatin as nephrotoxic, neurotoxic and ototoxic
agent [6]. The protective effects of Lisosan® G on human microvascular endothelial cells incubated
with oxidized LDL and Lisosan® G were evaluated, at different concentrations of the product observing
a decrease of some inflammatory markers [7]. The study of Lucchesi et al. [8] focused on the effects
of Lisosan® G as an antioxidant for human endothelial progenitor cells exposed to oxidative stress.
These cells, treated with the product before the incubation with hydrogen peroxide, increased the cell
viability and adhesion, and decreased cellular senescence. The liver was a further target of studies on
Lisosan® G: treatment with Lisosan® G on primary cultures of rat hepatocytes in presence of hydrogen
peroxide, induced the inactivation of NF-KB transcription factor involved in oxidative damage and an
up-regulation of Nrf2 responsible for cytoprotection by inducing detoxifying enzymes [9]. Despite the
studies focused on the evaluation of some health properties, no data concerning the phenolic content,
the microbiological composition, the prebiotic effect and the activity on Protein Tyrosine Phosphatase
1B (PTP1B) enzyme are available for this wholegrain fermented product. PTP1B enzyme is recognized
as an important target as negative regulator of insulin and leptin receptor signaling pathways [10].
The present work was aimed: (i) to investigate the chemical composition of Lisosan® G in terms of
free, bound, and total phenolic compounds, optimizing the extraction method; (ii) to investigate the
ability of several batches of Lisosan® G and of schaftoside to inhibit PTP1B enzyme; (iii) to assess the
microbial composition of Lisosan® G by sequencing of the bacterial 16 rRNA gene; and (iv) to evaluate
the prebiotic effect on the growth of a common human probiotic species Lactobacillus reuteri, a widely
distributed species recognized for its health properties in the human gut.
2. Results and Discussion
The phenolic molecules in the fermented wheat were studied as free, bound, and total phenols
by applying different extractive procedures, some of them already suggested for wheat. The first
aim was to verify if the fermentation process increases the free phenols as suggested by literature [2]
diminishing the bound fraction. To better study also some minor components, Lisosan® G was
fractionated by semipreparative HPLC and the content of several phenolic fractions was determined
by chromatographic and MS analysis. After the identification of the main phenolic constituents
and the optimization of the extractive and analytical procedures, several batches were investigated.
The ability of four batches of Lisosan® G and schaftoside standard to inhibit the PTP1B enzyme was
successively evaluated in vitro. Microbial composition was also assessed. The potential prebiotic
properties of Lisosan® G were tested on L. reuteri DSM 17938, a probiotic strain with demonstrated
potential beneficial effects in treating and preventing human diseases.
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2.1. Fractionation by Semipreparativa HPLC
Regarding the free phenols, the hydroalcoholic mixture (ethanol/H2O 8:2, v/v) and acidic
water showed comparable results, confirmed by the chromatographic profiles (data not shown).
Consequently, the aqueous extract was preferred as reference sample for the semipreparative HPLC.
According to Figure 1a and Table 1, some analytes detected at 280 nm (compounds 1–8) were recovered;
while at 350 nm C-flavonoids (9–11 and 13), ferulic acid (15), and some unknown phenols were recorded
(16–18). As expected in a fermented wheat, the presence of several free amino acids was confirmed by
HRMSn analyses in positive ion mode, in the more polar fractions (compounds 1–8), the compound
8 was identified as tryptophan (205 m/z) in co-presence with valine (118 m/z), proline (116 m/z)
and leucine (132 m/z), while the other analytes (1–7) to date remained unknown. The main detected
phenols were cinnamic derivatives and flavonoids, as shown in Figure 1a,b.
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profiles at 330 nm obtained for bound phenols with methods B and A on the whole flour, method BF 
on the residue from free phenol extraction;  and 10, neocarlinoside/isocarlinoside/carlinoside; 11, 
isoschaftoside; 13, schaftoside; 15, ferulic acid; 19, methyl ferulate and its chemical formula. 
From experimental data collected on the fractions by HRMS  and from the results in the 
literature on wheat [11–13], it was possible to identify a group of -glycosylated flavonoids ( 11 and 
13) present only in two of the fractions from semipreparative HPLC (Figure 2).  
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Figure 1. (a) Chromatographic profiles at 280 and 350 nm of the aqueous extract of Lisosan® G on
the Poroshell column, obtained applying the same gradient elution used for the semipreparative
HPLC. Compounds 1–8, unknowns; 9 and 10, neocarlinoside or its isobars, isocarlinoside/carlinoside;
11, isoschaftoside; 13, schaftoside; 15, ferulic acid; 16–18 unknowns; and (b) comparison of the HPLC
profiles at 330 nm obtained for bound phenols with methods B and A on the whole flour, method
BF on the residue from free phenol extraction; 9 and 10, neocarlinoside/isocarlinoside/carlinoside;
11, isoschaftoside; 13, schaftoside; 15, ferulic acid; 19, methyl ferulate and its chemical formula.
From exp rimental data collected on the fractions by HRMSn and from the results in the l teratur
on wheat [11–13], it was possible to identify a group of C-glycosylated flavonoids (9–11 and 13) present
only in two of the fractions from semipreparative HPLC (Figure 2).
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The profiles at 210 nm, a non-selective wavelength, confirm the exclusive presence of flavonoid 
compounds. The mass spectra of compounds  and 10 (Figure 3) showed the [M – H]? ion at 579 
in negative ionization, and similar UV–VIS spectra. The MS/MS experiments on 579  showed the 
loss of water (561 ) while the two fragment ions at 489 and 459 m/z are consistent with the loss of 
90 and 120 mass units, respectively. According to Iswaldi et al. [14], these losses correspond to cross-
g cleavages in the sugar moiety of -glycosilated flavonoids. In light of these findings, compounds 
 and 10 were tentatively identified as carlinoside, isocarlinoside, and/or neocarlinoside. These 
isobaric forms have only been reported once in wheat [13], as a plant response associated to drought 
tolerance. Compounds 11 and 13, with empirical formula C26 28 14, exhibited the same deprotonated 
ion at 563 . The ion species at 473  and 443 , obtained by MS/MS dissociation of the [M ?
H]? ion, showed again the losses of 90 and 120 mass units, respectively. From MS  experiments it was 
possible to confirm that the common fragment ion at 353  is originated from the 563  (after two 
successive losses of 120 and 90 mass units). According to literature [15,16], it was possible to identify 
11 as isoschaftoside and 13 as schaftoside. 
Figure 2. Chromatographic profiles at 210 nm and 350 nm of the two fractions
containing the C-glycosylated flavonoids recovered by semi-preparative HPLC; 9 and 10,
n ocarlinoside/isocarlinoside/carlinoside; 11, isoschaftoside; 13, schaftoside (UV–VIS spectra of peaks
9 and 13 and chemical formula of carlinoside and schaftoside are also shown).
The profiles at 210 nm, a n n-selective wavelength, confirm the exclusive presence of flavonoid
compounds. The mass spectra of compounds 9 and 10 (Figure 3) showed the [M − H]− ion at 579 m/z
in negative ionization, and similar UV–VIS spectra. The MS/MS experiments on 579 m/z showed
the loss of water (561 m/z) while the two fragment ions at 489 and 459 m/z are consistent with the
loss of 90 and 120 mass units, respectively. According to Iswaldi et al. [14], these losses correspond
to cross-ring cleavages in the sugar moiety of C-glycosilat d flavonoids. In light of these findings,
compounds 9 and 10 were tentatively identified as carlinoside, isocarlinoside, and/or neocarlinoside.
These isobaric forms have only been reported once in wheat [13], as a plant response associated to
drought tolerance. Compounds 11 and 13, with empirical formula C26H28O14, exhibited the same
deprotonated ion at 563 m/z. The ion species at 473 m/z and 443 m/z, obtained by MS/MS dissociation
of the [M − H]− ion, showed again the losses of 90 and 120 mass units, respectively. From MS3
experiments it was possible to confirm that the common fragment ion at 353 m/z is originated from the
563 m/z (after two successive losses of 120 and 90 mass units). According to literature [15,16], it was
possible to identify 11 as isoschaftoside and 13 as schaftoside.
The sp ctral data in positive and neg tive ion mode for the pool of C-glycosilate flavonoids
are reported in Table 1. Compound 15 was identified as ferulic acid as also confirmed by the MS2
spectrum of its deprotonated molecular ion showing the species at 178 m/z, corresponding to the loss
of a methyl group, and 134 m/z from the successive loss of carbon dioxide (59 mass units).
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Figure 3. MS2 and MS3 spectra (a) of carlinoside/isocarlinoside/neocarlinoside (10) and MS2 and MS4
spectra (b) of isoschaftoside (11). All MSn spectra were recorded at the optimized collision energy
using wideband activation. The fragmentation of the glycosidic moiety, originating the losses of 90 and
120 mass units, is also shown.
Table 1. C-glycosylated flavonoids detected in Lisosan® G by MSn experiments.
Positive Ion MSn Negative Ion MSn
Analytes
C-glycosylated
Flavonoids
[M − H]+ Fragment Ions [M − H]− Fragment Ions
9
Carlinoside/
Neocarlinoside/
Isocarlinoside
581 563; 545; 527; 509 579 489; 399
10
Carlinoside/
Neocarlinoside/
Isocarlinoside
581 563; 545; 527; 509 579 489; 399
11 Isoschaftoside 565 547; 529; 511; 427; 349 563 473; 353; 325
13 Schaftoside 565 547; 529; 511; 427; 349 563 473; 353; 325
2.2. Extraction of Free, Bound, and Total Phenols
The free phenols in the first batch of Lisosan® G were 38 mg/100 g (Table 2), a comparable
amount to those reported by other authors for wheat, in which the concentrations were lower than
20 mg/100 g [11,17]. Regarding the bound forms, it was verified if the fermentation process can induce
a release of the bound phenols. To recover this fraction, almost all the available studies on cereals
reported the use of strong basic hydrolysis with NaOH (from 2 M to 10 M), usually at room temperature;
the acidic hydrolysis was reported as not suitable, due to the de radation of hydroxycinnamic and
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benzoic acids [17,18]. Nevertheless, we observed that few data are available on the effects of different
basic or acidic procedures on the chemical stability of phenols during their extraction from cereals.
Consequently, with the aim of selecting the best method to effectively recover the phenolic fraction,
a methanol solution with 4 M NaOH (Method BS) was firstly tested and compared with a softer
condition with 0.1 M NaOH (Method B). HPLC-DAD analysis highlighted that the former procedure
induced a partial degradation of the phenolic compounds when compared with the weaker basic
hydrolysis: the use of 4 M NaOH led to the degradation of methyl ferulate converted in ferulic acid,
and of compounds 9 and 10 (Table 2).
At the same time, Lisosan® G was also treated according to Arranz et al. [4] to better investigate
the effects of the acidic hydrolysis on the phenolic fraction. The chromatographic profiles of the sample
after basic hydrolysis with 0.1 M NaOH present two main compounds: ferulic acid (15) and methyl
ferulate (19), while the acidic hydrolysis (Figure 1b) shows only the presence of methyl ferulate (19),
a compound previously detected in rice [19] but to date never reported in wheat. Presumably,
the absence of methyl ferulate in literature could be attributable to the applied strong basic hydrolysis
(from 2 M to 10 M) causing the formation of ferulic acid by hydrolysis of the ester bond. On the other
hand, the use of a basic medium but in a weaker condition could avoid this reaction. To verify this
hypothesis, pure ferulic acid was treated in the same way of Lisosan® G with Method B (0.1 M NaOH
in methanol); as expected, the formation of methyl ferulate was not observed and it was possible to
conclude that this ester is not an artefact of the extraction process, but is naturally present in Lisosan®
G. Observing the profile obtained from the basic extraction (Method BF) of the solid residue of Lisosan
®
G remaining after recovery of the free phenols, it was possible to assess that C-glycosylated flavonoids
(9–13) were only present in free form (Figure 1b). In terms of extraction efficiency, the methods tested
for the recovery of bound phenols gave different results. The strong basic hydrolysis (Method BS)
led to a partial degradation of the compounds of interest (some minor C-flavonoids) and reduced the
total phenolic recovery, in comparison to the other applied methods (Table 2a). A strong increase in
solvent/dry sample ratio (from method BF 1:25 w/v, to method B, 1:100 w/v) guaranteed a better
recovery (up to 60% higher) in terms of total phenols (Table 2a).
The basic hydrolysis (B) and the acidic procedure (A) applied to LG1 batch were the more
advantageous, giving the highest yields in total phenols, with similar values of 279 mg/100 g and
265 mg/100 g, respectively. It is worth noting that the acidic hydrolysis (Table 2b, column LG1)
maintained almost the same amount of the C-glycosylated flavonoids (compounds 9–11 and 13)
extracted with the simple procedure for free phenols (Table 2a, column FP). The acidic hydrolysis was
chosen as a reliable method to compare the four Lisosan® G batches for the following reasons: (i) the
quantitative data from the methods A were almost the same obtained applying the basic procedure
B, but in the latter case applying a four times higher extractive ratio, (ii) the phenolic compounds
are chemically stable in acidic media differently to what can happen in the basic media, in which the
more hydroxylated flavonoids can go toward a partial degradation, and (iii) the same acid procedure
applied to other cereals (data not shown) gave again the highest recovery in terms of total phenols.
The first batch (LG1) was the richest in terms of total phenolic content; the LG2 and LG3 resulted
very similar otherwise the LG4 was the poorest (Table 2b). These variable amounts of the phenolic
components is in agreement with what expected for a natural product with a complex composition.
Overall, in light with the findings in Table 2, it was possible to conclude that this type of fermentation
is not able to increase the release of the bound phenolic fraction that remains higher than 80%, more or
less the same amount measured in unfermented wheat [17].
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Table 2. Concentration of the phenolic compounds identified in Lisosan® G applying different extraction
methods and evaluated through HPLC-DAD by suitable external standards. (a) free phenols (FP), and total
phenols determined after basic hydrolyses (methods BS, BF, B) applied to Lisosan
® G first batch (LG1);
(b) total phenols determined after acidic hydrolysis (method A) applied to the four batches of Lisosan® G
(LG1; LG2; LG3; LG4). The data are a mean of three independent extractions expressed as mg/100 g dry
product. The relative standard deviation (RSD) was below 4% for all the detected phenols.
(a) Free (FP) and Total Phenols (Bs, Bf and B) from Basic Hydrolyses in mg/100 g
Compounds FP Bs
BF
(on whole flour)
B
Carlinoside/isocarlinoside/
neocarlinoside (9)
6 - 4 2
Carlinoside/isocarlinoside/
neocarlinoside (10)
5 - 3 2
Isoschaftoside (11) 7 6 7 13
Schaftoside (13) 17 12 15 22
Ferulic Acid (15) 3 223 12 48
Methyl Ferulate (19) - - 70 178
Total ferulates 3 223 82 226
Total phenols 38 241 111 265
(b) Total Phenols Obtained Applying the Acidic Hydrolysis mg/100g
Compounds LG1 LG2 LG3 LG4
Carlinoside/isocarlinoside/
neocarlinoside (9)
2 2 2 2
Carlinoside/isocarlinoside/
neocarlinoside (10)
3 2 3 3
Isoschaftoside (11) 10 6 6 6
Schaftoside (13) 17 10 9 10
Ferulic Acid (15) 2 2 3 2
Methyl Ferulate (19) 245 197 208 158
Total ferulates 247 199 211 160
Total phenols 279 219 231 181
2.3. Inhibition of PTP1B
The four batches of Lisosan® G and the schaftoside pure standard were in vitro evaluated for their
inhibitory effect on PTP1B, known as a negative regulator of insulin receptors. The whole aqueous
extracts (LG1–LG4) at a final concentration of 125 mg/mL and schaftoside, as main flavonoid, at a final
concentration of 0.15 mg/mL, were tested adding different amount of extracts (Figure 4).
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Figure 4. Residual activity of PTP1B enzyme (in vitro %); schaftoside standard (Sca) and Lisosan®
G extracts (LG1–LG4) were tested at two concentrations: (a) 10 µL/mL corresponding to 2.7 µM for
schaftoside and 1.25 mg/mL for Lisosan® G extracts; (b) 50 µL/mL corresponding to 13.5 µM for
schaftoside and 6.25 mg/mL for Lisosan® G extracts. Ctrl for control (see experimental section).
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The choice of testing schaftoside was also due to the inhibitory activity already showed by
flavonoids on PTP1B enzyme as reported by literature [20]. The results pointed out that the whole
extracts and the schaftoside were not able to inhibit the enzyme in diluted (10 µL/mL) and in
concentrate (50 µL/mL) solutions. Otherwise the pure schaftoside showed a complete inhibition
of the enzyme in a concentration of 13.5 µM (Figure 4b) and an IC50 value of 6.4 µM (Figure 5a).
Considering that the extracts, containing the corresponding amount of schaftoside, resulted not
active in the enzymatic assay, we could speculate that other compounds present in Lisosan® G could
act as antagonists of schaftoside, presumably hindering its interaction with PTP1B enzyme. This
hypothesis was verified by using a myricetin standard added to the LG1 and LG2 extracts. The choice
of myricetin was due to the fact that this flavonol previously showed an IC50 of 0.47 µM on PTP1B
enzyme (data not shown). Analogously to what observed for the schaftoside, the results in Figure 5b
pointed out that the addition of myricetin in the Lisosan® G extracts reduced the inhibitory activity of
the molecule alone. In light with these findings, we can conclude that Lisosan® G contains unknown
molecules that impede the interaction with the enzyme. These results agrees with recent evidence that
confirmed the presence of different allosteric sites on the enzyme surface involved in the regulation of
the enzyme activity [21]. Furthermore, it was possible to affirm that the cinnamic components alone
were not responsible for such higher inhibitory activity; in fact from literature, ferulic acid in high
concentration (100 µM) only exerted a weak inhibition (15%) on PTP1B [22]. Further analyses will
be conducted to better define the inhibitory mechanism of schaftoside and the relationship with the
applied dose.
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Figure 5. (a) IC50 of schaftoside. (b) Residual activity of PTP1B enzyme (in vitro %) of: Ctrl for control
(see experimental section), myricetin standard (Myr), Lisosan® G extracts alone (LG1–LG2), and added
with myricetin (LG1+Myr; LG2+Myr). The extracts were tested at 10 µL/mL corresponding to 0.5 µM
for myricetin and 1.25 mg/mL for Lisosan® G extracts.
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2.4. Microbial Composition of Lisosan® G
Bacteriological analysis firstly excluded the presence of microbial contaminants typical of food
specimens, such as coliforms and staphylococci (Figure 6).
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Since the microbial composition of Lisosan G is unknown, quantification of specific bacterial
species of interest by Real-Time PCR or q-PCR was not applied. Next-generation sequencing was chosen
as suitable tool to perform the qualitative characterization of bacterial composition. The 16S rRNA
gene sequencing was applied to identify the microbial composition of Lisosan® G (Table 3) with
Lactobacillus (45.4%), Enterococcus (28%), and Pediococcus (17%) as the main bacterial genera.
Table 3. Microbial composition of Lisosan® G (LG1). Number of sequenced reads and amount (%) of
identified taxa were reported.
N. Reads Amount (%)
Phylum Class Order Family Genus
Firmicutes Bac lli Lactobaci lales Lactobaci laceae Lactobacillus 47,344 45.4%
Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus 29,195 28.0%
Firmicutes Bacilli Lactobacillales Lactobacillaceae Pediococcus 17,711 17.0%
Firmicutes Bacilli Lactobacillales Unclassified Unclassified 3863 3.7%
Firmicutes Bacilli Lactobacillales Lactobacillaceae Unclassified 3391 3.3%
Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus 1218 1.2%
Unclassified Unclassified Unclassified Unclassified 918 0.9%
Others 637 0.6%
Total 104,277
By BLAST alignment we found that the best hits for species identification (99% of identity)
were Lactobacillus fermentum, Enterococcus faecium, and Pediococcus acidiliacti. Generally, numerous
fermenting bacteria, especially lactic acid bacteria (LAB), have been identified in sourdoughs, including
Lactobacillus and Pediococcus spp. In addition to acidification, the proteolytic activity of LAB allows
release of compounds which can promote growth or inhibition and metabolic activities of other
microorganisms, as well as organoleptic characteristics. Enterococcus genus includes known probiotic
strains and was considered a good candidate for co-culture in food fermentation processes [23].
2.5. Activity on Lactobacillus reuteri
Lactobacillus reuteri is a common component of the microbiota of human and animal intestine
and it is widely used in probiotic formulations targeted to infants and adults to reduce the incidence
and severity of diarrhea, prevent colics and necrotic enterocolitis, and maintain a functional mucosal
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barrier [24]. As shown in Figure 7, Lisosan® G was capable of stimulating the growth of L. reuteri
DSM 17938 by more than 1 Log (from 6.7 to 7.8) after 48 h of incubation; even if growth was significantly
lower (p < 0.05) with respect to that on glucose. The ability to increase the growth of this microorganism
is certainly of interest for this fermented matrix characterized by the presence of probiotic strains
and phenolic compounds potentially able to exert growth inhibition of harmful bacteria. The reason
for the lack of difference in growth potential when Lisosan® G was tested at different concentrations
(0.5 and 1%) may also be related to the copresence of different molecules and a broad spectrum of
action of this complex product. The beneficial effects of Lisosan® G on human health have already
been demonstrated, but prebiotic effects have not been described yet.
1 
 
Figure 7. Ability of Lisosan® G (LG1) tested at different concentration (0.5 and 1%) in stimulating the
growth of L. reuteri.
3. Materials and Methods
3.1. Samples and Reagents
Four batches of Lisosan® G (LG1, LG2, LG3, LG4), a food supplement obtained from lysed fine bran
and germ of organic wheat grains (Triticum aestivum), were provided by Agrisan Srl Company, Larciano
(Pistoia, Italy). All solvents used were analytical HPLC grade from Sigma Aldrich (St. Louis, MI, USA).
Water was ultrapure (Milli-Q®, Merck Millipore, Darmstad, Germany), ferulic acid (purity ≥ 99%),
and apigenin (purity ≥ 95%) were purchased from Extrasynthese (Genay, France).
3.2. Extraction of Phenolic Compounds
Free phenols. Lisosan® G, LG1, (250 mg) was extracted with EtOH/H2O 80:20 v/v under magnetic
stirring in ultrasonic bath for about 15 min. The extract was centrifuged at 5000 rpm for 10 min. Ten mL
of the supernatant were evaporated to dryness and the residue re-dissolved in 1.5 mL of acidified H2O
(1% HCOOH). The same extraction was performed with H2O acidified with 1% HCOOH.
Bound and total phenols. An acidic hydrolysis (method A) and three different basic hydrolyses
(BF, B and BS methods) were applied on the fermented wheat as reported below. All the hydrolyses
were carried out by the help of an ultrasonic bath (40 MHz). Method BF: 1 g of the sample was
extracted with 25 mL of NaOH 0.1 M in MeOH/H2O 7:3 v/v, sonicated for 1 h at 60
◦C. The pH was
adjusted to neutrality with acetic acid and the solution centrifuged at 5000 rpm for 10 min to recover
the supernatant. The same procedure was applied to the solid residue recovered after the extraction of
free phenols. Method B was the same of method BF with only a difference on the solvent-dry sample
ratio:1 g of Lisosan® G was extracted in 100 mL NaOH 0.1 M in MeOH/H2O 7:3 v/v. Method BS: 1 g
Molecules 2019, 24, 1120 11 of 15
of the sample was extracted in 25 mL of MeOH/H20 7:3 v/v with NaOH 4 M, sonicated for 1 h at
60 ◦C. The pH was adjusted to neutrality with CH3COOH and the solution diluted to a final volume
of 50 mL with MeOH/H20 7:3 v/v; the sample was then centrifuged at 5000 rpm for 10 min to recover
the supernatant. Method A was an acidic hydrolysis performed on the four batches (LG1–LG4) using
the mixture MeOH/H2SO4 9:1 v/v: 1 g of Lisosan
® G was extracted in 25 mL, sonicated for 2 h at
60 ◦C, and then centrifuged at 5000 rpm for 10 min to recover the supernatant.
3.3. Fractionation by Semipreparative HPLC
About 700 mg of Lisosan® G (LG1) were almost completely dissolved in 150 mL of HCOOH (1%)
under magnetic stirring for 15 min at 60 ◦C. After centrifugation (5000 rpm, 10 min), the supernatant
was dried under vacuum and re-dissolved in 6 mL of distilled water obtaining the total Lisosan® G
extract. This extract was fractionated by semipreparative HPLC using a Hewlett Packard 1050 series
and a Polaris RP-C18 Ether column (250× 10 mm, 5 µm, Varian, Germany); 12 fractions were recovered
after 30 injections of 100 µL. Elution was carried out at a flow rate of 4 mL min−1 with CH3CN as
solvent A and H2O (0.1% HCOOH) as solvent B. A linear elution gradient was employed: solvent A
was increased from 0% to 10% in 10 min, from 10% to 15% in 10 min, from 15% to 30% in 10 min, from
30% to 100% in 5 min with a final plateau of 10 min. Total time of analysis was 45 min, equilibration
time 10 min. The collection was carried out monitoring the chromatogram at 280 nm up to 15 min,
successively 350 nm was the wavelength selected to detect and recover the flavonoids. The fractions
were dried, re-dissolved in 1 mL of water, and controlled by analytical HPLC-DAD and MSn analysis.
3.4. Inhibition Test on PTP1B Enzyme
All four batches were treated as follow: the maximum amount of Lisosan® G (250 mg) was
dissolved in 50 mL of acidified H2O (1% HCOOH), after a magnetic stirring of 15 min. The extracts
were then evaporated to dryness and re-dissolved in 2 mL of water. These extracts (LG1–LG4), the pure
schaftoside (at concentration 2.7 µM), and the pure myricetin (at concentration 0.5 µM) were evaluated
as inhibitors of the enzyme PTP1B. Furthermore, the IC50 was also determined for the schaftoside.
Enzymatic assays were carried out using human recombinant PTP1B and p-nitrophenylphosphate
(pNPP) as reference substrate. According to Paoli et al. [25], the pNPP (2.5 mM final concentration)
was dissolved in sodium β,β-dimethyl glutarate buffer (75 mM, pH 7.0), containing 1 mM EDTA and
1 mM dithiothreitol; this solution was used as control (Ctr). Reactions were started by addition of
aliquots of the enzyme and stopped by adding 2 mL of KOH 0.2 M. The released p-nitrophenolate
was quantified by reading absorbance of the final solution at 400 nm (ε = 18,000 M−1 cm−1). The net
hydrolysis rate was determined subtracting the value of spontaneous hydrolysis rate of pNPP from
each sample. The inhibitory power of LG extracts and schaftoside standard was tested adding different
amount of extracts (10 and 50 µL/mL) for each assay. Then, the percentage of inhibition was calculated
normalizing the absorbance values obtained for assays carried out in the presence of inhibitor versus
the control test. All the results were expressed as a mean of three independent experiments.
3.5. Bacteriological Analysis
In order to exclude the presence of bacterial contaminants of food specimens, such as coliforms
and staphylococci, LG1 batch was tested in McConkey III medium (Oxoid Basingstone, UK; for the
detection of coliform, bacilli, Salmonella and Shigella species) and in Mannitol salt medium (Oxoid
Basingstone, UK; for detection of presumptive pathogenic staphylococci). Lisosan® G (500 mg) were
directly plated on the two different media and, after incubation for 24–48 h, presence of potential
microbial contaminants were evaluated.
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3.6. 16S Ribosomal RNA Gene Amplicons Preparation and Illumine MISEQ and Data Analysis
By LG1 batch, library of 16S rRNA gene amplicons was prepared by IGA Technology Services
(Udine, Italy) through amplification of the V3–V4 hypervariable region. The standard protocol was
followed according to the 16S metagenomic sequencing library preparation guide from Illumina
(Part #15044223 Rev. B; https://support.illumina.com/, San Diego, CA, USA). Pooled V3–V4
amplicon libraries were sequenced using the Illumina MiSeq platform. Sequence data are available at
European Bioinformatics Insitute-EMBL-EBI database [26], under the accession number PRJEB30414.
Reads (total number 126.669) were further processed using the MICCA pipeline (version 1.6,
http://compmetagen.github.io/micca/, San Diego, CA, USA), as reported by Di Paola et al. [27].
A total of 104.277 Operational Taxonomic Units (OTUs) were assigned by clustering the sequences
with a threshold of 97% pair-wise identity. OTU tables for each taxonomic level were created.
To deep at species level sequence alignment using Basic Local Alignment Search Tool nucleotide
(BLASTn) software (San Diego, CA, USA) in the National Center for Biotechnology Information (NCBI)
database was performed. The highest percentage of identity (query cover 100–99% and identity 99%).
Expectation value (E-value) was used to select significant BLAST hits, keeping only outcomes with the
lowest E-value (minimal E-value of 10−3).
3.7. Test on Lactobacillus reuteri
The strain used was obtained from the German Collection of Microorganisms and Cell Cultures
(L. reuteri DSM 17938). The lyophilized strain was re-vitalized in the Man Rogosa Sharpe (MRS)
medium (Oxoid, Basingstone, UK) supplemented with 0.05% cysteine and incubated in anaerobic
chamber at 37 ◦C for 24 h. The MRS medium composition was modified to perform the growth
experiment with Lisosan® G in order to eliminate glucose and reduce the concentration of potential
growth factors, as described in Khatib et al. [28]. The modified medium is referred to as m-MRS.
The prebiotic activity was evaluated using Lisosan® G, LG1 batch, at 0.5% and 1% (w/v) in m-MRS.
A positive growth control was performed using m-MRS with 0.5% (w/v) glucose and a negative control
in m-MRS with no added carbon source. The medium containing Lisosan® G as potential carbon source
was prepared as follows: the m-MRS ingredients were weighed and the medium autoclaved at 120 ◦C
for 15 min. Lisosan® G was then added, the solution stirred at 80 ◦C and then autoclaved again at
102 ◦C for 10 min. The strain was grown overnight in MRS, centrifuged, washed in saline (0.9% NaCl),
and re-suspended in saline to obtain an absorbance of 0.7 mAu at 600 nm. This suspension was used
to inoculate at 2% (v/v) the flasks containing the m-MRS medium plus Lisosan® G or glucose or the
negative control with no carbon source. The tubes were incubated at 37 ◦C in anaerobic conditions
for 48 h and a 1 mL culture was sampled from each flask, serially diluted, and inoculated on MRS
agar plates for viable bacterial counts at pre-established times (0, 24, 30, and 48 h of incubation). Upon
incubation, the number of colonies, corresponding to the number of viable cells, were counted and
expressed as CFU mL−1. The number was transformed into a log10 value (log CFU mL−1).
3.8. Analytical HPLC-DAD
The extracts from Lisosan® G were centrifuged (5000 rpm, 10 min) and analyzed using a HP 1200L
liquid chromatograph equipped with a DAD detector (Agilent Technologies, Palo Alto, CA, USA)
using a Poroshell 120, EC-C18 column (150 × 3 mm, 2.7 µm, Agilent, USA). The solvents for the mobile
phase were (A) CH3CN and (B) 0.1% formic acid/water; the multi-step linear solvent gradient was:
0–5 min 0–10% A; 5–10 min 10–15% A; 10–20 min 15–30% A; 20–25 min 30–35% A; 25–28 min 35–40%
A; 28–31 min 40–45% A; 31–42 min 100% A; 42–47 min 100–0% A; equilibration time 5 min; flow
rate 0.4 mL min−1; injection volume 10 µL. The following wavelengths were simultaneously selected:
240 nm, 280 nm, 330 nm, 350 nm.
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3.9. MS Analysis of Lisosan® G fractions
The isolated fractions by semipreparative HPLC were analyzed by direct infusion in ESI-HRMS
and MSn on a LTQ-Orbitrap (Thermo Scientific, Bremen, Germany). Each fraction was taken to dryness
by evaporation under vacuum and re-suspended in a CH3CN/H2O mixture, containing 0.1% formic
acid. This solution was infused by syringe into the ESI interface of the instrument. Sheath and auxiliary
gas flow rates were 10 and 2 (arbitrary units), respectively; capillary voltage and tube lens voltages,
as the collision energy and wideband activation voltage in MSn experiments, were optimized for each
compound of interest during the infusion. The mass spectrometer was calibrated with the standard
mixture indicated by the producer immediately before the acquisition of the samples, both in positive
and in negative ion mode.
3.10. Quantitative Determination of Phenolic Acids and Flavonoids
The phenolic acids were evaluated using a five-point calibration curve of ferulic acid at 330 nm,
(R2 = 1, linearity range 0–0.21 µg), while the flavonoid content was determined using a five-point
calibration curve of apigenin at 350 nm (R2 = 0.999, linearity range 0–0.80 µg).
3.11. Statistical Analysis
Each experiment was performed in triplicate, and the results were expressed as the mean values±
SD; the EXCEL software (version 2013, Microsoft Corporation, Redmond, WA, USA) in-house routines
were applied. Significance in the prebiotic properties experiment was calculated within each evaluation
time with a t-test, using the MEANS procedure (SAS). Statistical analysis of data from PTP1B was
performed using the Student t-tests, using OriginPro 2018 (OriginLab Corporation, Northampton,
MA, 01060, USA http://www.originlab.com) The differences between the groups were considered
significant when p < 0.05.
4. Conclusions
This work improves knowledge on the composition and properties of this fermented grain, and
it is the first report to focus on the content of free and bound phenolic compounds in Lisosan® G.
Contrary to what reported in literature, the bound phenols remained high (more than 80%), although
Lisosan® G was obtained after a fermentation process, usually described as able to increase hydrolytic
processes and to strongly reduce the aliquot of bound phenols in cereals. Again, despite some data in
the literature, the acidic hydrolysis was able to extract the highest amount of cinnamic derivatives,
without degradation of the pool of C-glycosylated flavonoids. It was demonstrated that applying both
soft basic and acidic hydrolysis on the whole flour it was possible to recover free and bound phenols
through only one extractive step with higher yields compared to those obtained with the stronger basic
hydrolysis suggested in the literature to date. Regarding the microbial characterization, it showed
the presence of bacterial genera with fermentative capability such as Lactobacillus, Pediococcus, and
Enterococcus, generally recognized as safe and used in the production of fermented food. The proteolytic
activity of these bacteria can contribute to the release of compounds, as phenols, growth of beneficial
bacteria as L. reuteri, and inhibition of harmful bacteria. For the first time, a prebiotic effect on L. reuteri
strain, widely used in probiotic formulation targeted to infants, was highlighted. This fermented
wheat resulted not able to inhibit the PTP1B enzyme in vitro, otherwise the pure schaftoside, a main
C-flavonoid of Lisosan® G, showed a strong inhibition power. Schaftoside was tested for the first
time on PTP1B enzyme and was active as inhibitor at µM concentration (13.5 µM). Our findings
open new perspectives to investigate on the role played by this C-glycosylated flavonoid and its
analogous, typically present in wheat and in other cereals. Further studies are desirable to clarify the
mechanism linked to the action of schaftoside and to test also other similar C-flavonoids on PTP1B
enzyme. The International Diabetes Federation announced that the global population of diabetics
in 2015 was close to 400 million, and this number could rise to 600 million in 2040. In this context,
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research on new functional foods that can help stem the onset of this disease in the near future is
recognized as strategic. Overall, our results provide further insights on the nutraceutical potential of
this fermented food, whose beneficial effects were previously demonstrated by recent in vivo and ex
vivo experiments.
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